Showing 1 - 20 results of 14,488 for search '(( design based decreased ) OR ( a marker decrease ))', query time: 0.71s Refine Results
  1. 1

    The proportion of alveolar type 1 cells decreases in murine hypoplastic congenital diaphragmatic hernia lungs by Tram Mai Nguyen (6597863)

    Published 2019
    “…Based on this model, the alveolar epithelium showed a decrease in the number of alveolar type 1 cell in congenital diaphragmatic hernia lungs while type 2 cell population remains unchanged.…”
  2. 2
  3. 3

    Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells by Maciej Wnuk (825978)

    Published 2024
    “…MNP@CD26@17D-mediated ferroptosis might be executed by ferritinophagy as judged by elevated levels of the ferritinophagy marker NCOA4 and a decreased pool of ferritin. As 24 h treatment with MNP@CD26@17D did not induce hemolysis in human erythrocytes <i>in vitro</i>, this newly designed nanoplatform could be considered as an optimal multifunctional tool to target and eliminate senescent cells of skin origin, overcoming their apoptosis resistance.…”
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Biodegradable Fiducial Markers for Bimodal Near-Infrared Fluorescence- and X‑ray-Based Imaging by Żaneta Górecka (3702526)

    Published 2022
    “…This study aimed to evaluate, for the first time, implantable, biodegradable fiducial markers (FMs), which were designed for bimodal, near-infrared fluorescence-based (NIRF) and X-ray-based imaging. …”
  10. 10

    Biodegradable Fiducial Markers for Bimodal Near-Infrared Fluorescence- and X‑ray-Based Imaging by Żaneta Górecka (3702526)

    Published 2022
    “…This study aimed to evaluate, for the first time, implantable, biodegradable fiducial markers (FMs), which were designed for bimodal, near-infrared fluorescence-based (NIRF) and X-ray-based imaging. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
  20. 20